Drive for 75: Resources from Week 27

Workforce | September 10, 2021 | by Dee Pekruhn, Jill Schumann

LeadingAge Coronavirus Update Calls feature brief segments called “Drive for 75” to promote the successful vaccination of our aging services providers’ workforce, and as needed, residents. We will cover developments in the news, research, and innovative practices that support our members in attaining high vaccination rates.

This Week’s Highlights:

Volume Sixty Four: Air Date 9.8.21. New Study on Vaccine Safety

The Axios Ipsos poll for August 27-30 indicated that the number of people who are vaccinated and who say they are likely or somewhat likely to get the vaccine is rising, albeit slowly. And 20% of people polled who indicated that they would not, or were not likely, to get the vaccine has dropped to 20%, the lowest number since this regular polling was initiated a year ago.

A study published September 3 in JAMA should be encouraging to those who have been worried about the vaccine’s safety. Federal and Kaiser Permanente researchers combing the health records of 6.2 million patients found no serious health effects that could be linked to the 2 mRNA COVID-19 vaccines. The study reports the first comprehensive findings of the Vaccine Safety Datalink (VSD), which studies patient records for 12 million people in 5 Kaiser Permanente service regions along with HealthPartners in Minneapolis, the Marshfield Clinic in Wisconsin, and Denver Health.

The researchers examined 23 potential health effects, chosen because they had been included in previous vaccine studies, were of particular concern as an effect of COVID-19, were noted during the COVID-19 clinical trials, or were added after public health officials reported increased cases among vaccinated people. The study showed that there were not statistically significant medical outcomes for all but one of these 23 health-effects in the period 1-21 days after vaccination compared to 22-42 days post-vaccination. They controlled for age and other demographic and pre-existing medical factors.

However, study authors did discuss cases of confirmed myocarditis and pericarditis among young people. The authors calculated that among patients 12 to 39 years old, there is a risk of 6.3 additional myocarditis cases per million doses during the first week after vaccination. However, other research has calculated a significantly higher risk of myocarditis from COVID-19 than from the vaccine. So let’s get shots in arms.